Akademisyen
HAKAN ÖZER
DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)
İZMİR BAKIRÇAY ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Nefroloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 49
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
4
Q2
7
Q3
11
Q4
10
WoS (JCR)
Q1
2
Q2
5
Q3
10
Q4
10
TR Index
13
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
42.6%
Üst %1 payı
0.0%
Üst %10 payı
2.2%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 The relationship between multiple plasma biomarker levels and renal disease activity in Fabry disease YÖKSİS SJR Q1 JCR Q2 OpenAlex 77.8%
- 2025 In Which Hemodialysis Patients Have Covid-19 Cause Death More Often? YÖKSİS OpenAlex 18.8%
- 2025 How did the COVID-19 pandemic period affect the patients on the cadaver waiting list? A single-center experience YÖKSİS TR Index OpenAlex 20.7%
- 2024 Overlooked factor in the etiology of pruritus in hemodialysis patients: Ultrafiltration volume YÖKSİS SJR Q3 JCR Q3 OpenAlex 74.2%
- 2024 Evaluation of the Association of Serum Sclerostin and Carotid Intima Media Thickness with Chronic Kidney Failure and Kidney Transplantation YÖKSİS SJR Q4 JCR Q4 OpenAlex 71.0%
- 2024 Biopsy-proven BK virus nephropathy in renal transplant recipients: A multi-central study from Turkey (BK-TURK STUDY). YÖKSİS SJR Q3 JCR Q4 OpenAlex 14.3%
- 2024 Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick? YÖKSİS SJR Q3 OpenAlex 10.2%
- 2024 Combined Use of Different Vaccine Models for Covid-19 And The Side-Effect Profile: A Single-Center Experience YÖKSİS OpenAlex 0.9%
- 2024 Acute cholestatic hepatitis due to infectious mononucleosis: A case report YÖKSİS OpenAlex 49.5%
- 2024 Can Cardiovascular Risk Be Simply Estimated in Nonalcoholic Fatty Liver Disease Patients? YÖKSİS TR Index SJR Q4 OpenAlex 27.9%
- 2023 Sclerostin and TNF-related weak inducer of apoptosis: can they be important in the patients with glomerulonephritis? YÖKSİS SJR Q3 JCR Q2 OpenAlex 45.8%
- 2023 Unknown criminals for kidney: Acute interstitial nephritis due to lavender tea YÖKSİS SJR Q2 JCR Q3 OpenAlex 45.8%
- 2023 Could immune cells be associated with nephropathy in Fabry disease patients? YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.4%
- 2023 Individualized hemodialysis: Is similar hemodialysis adequacy possible using less water? possible using less water? YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 61.8%
- 2023 An update on dıagnosıs and treatment of ANCA assocıated renal vasculıtıs YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.9%
- 2023 A Rare Case: Improved Heart Failure with Anti-Complement Therapy in Complement-Dependent Hemolytic Uremic Syndrome YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 15.3%
- 2023 Two Different Presentation of C3 Glomerulonephritis Treated with Eculizumab: Two Cases and Brief Overview YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 15.4%
- 2023 Membranous Nephropathy: Current Understanding in The Light of New Advances YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 46.4%
- 2023 Tonic-Clonic Seizure in Patient With SLE: Posterior Reversible Encephalopathy Syndrome, or a Neuropsychiatric Manifestation of SLE? YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.4%
- 2023 What Do Donor-Specific Antibody Changes Mean in Kidney Transplant Patients? YÖKSİS OpenAlex 21.8%